Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Supplement: Noncommunicable Disease Risk Factors in Developing Countries: Policy Perspectives
Semaglutide (the active ingredient in Wegovy and Ozempic) targets the GLP-1 receptor
People on GLP-1 therapy should watch for: Back pain that may indicate a vertebral compression fracture Any fall, even from standing height, that results in a fracture (a fragility fracture) Gradual height loss over years, which can indicate vertebral fractures Hip, wrist, or shoulder pain after minor trauma These are not early warning signs of bone thinning in real time
This is because GLP-1 agonists are also effective for weight loss, and semaglutide (the active Ozempic ingredient) is licensed under the brand name Wegovy for weight loss in the UK
manufacturing capacity
US$ 20.85
US$ 28.35
US$ 21.59
US$ 24.84
US$ 23.64
US$ 20.45
US$ 20.50
US$ 26.55
